Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Danish Economy Nearly Stalls as Pharma Slump Offsets Wider Gains
Denmark 's economy barely expanded at the end of last year as a slump in the pharmaceutical industry, dominated by Novo Nordisk A/S, weighed on overall growth. Gross domestic product rose 0.2% in the fourth quarter from the previous three months…
Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment
Shares of Japan's Sumitomo Pharma fell over 12%. Japanese government endorsed the company's iPS cell-based therapy for Parkinson's and heart disease. Shares of Japanese drugmaker Sumitomo Pharma fell over 12% Friday on what appeared to be…
Pharma Poised For 10 pc Revenue Growth In FY27
Chennai: The pharmaceutical sector is projected to grow its revenues by 10 per cent in FY27, driven by healthy domestic sales and increased traction in the contract development and manufacturing organisation (CDMO) business. 'Indian pharma is…
The FDA talks over-the-counter freedom. Big Pharma profits from keeping it restricted.
Food and Drug Administration (FDA) Commissioner Marty Makary recently stated that when it comes to drugs that currently require a prescription, 'everything should be over the counter' (OTC) unless they are unsafe or need monitoring. There are…
Trade experts flag risks to agriculture, pharma and policy space in India's US, EU FTAs
Trade experts have raised wide-ranging concerns over India's proposed and recently concluded free trade agreements (FTAs) with the United States and the European Union, warning that the pacts could reshape key sectors, from agriculture and…
BIT Capital GmbH Reduces Holdings in BridgeBio Pharma, Inc. $BBIO
BIT Capital GmbH cut its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 94.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,056 shares of…
GSA Capital Partners LLP Invests $977,000 in Urogen Pharma $URGN
GSA Capital Partners LLP acquired a new stake in shares of Urogen Pharma (NASDAQ:URGN - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 48,964 shares of the company's stock…
NewAmsterdam Pharma (NASDAQ:NAMS) Rating Increased to Strong-Buy at HC Wainwright
NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) was upgraded by analysts at HC Wainwright to a 'strong-buy' rating in a note issued to investors on Thursday, Zacks.com reports. HC Wainwright also issued estimates for NewAmsterdam Pharma's Q3…
Aberdeen Group plc Sells 90,180 Shares of Ascendis Pharma A/S $ASND
Aberdeen Group plc decreased its holdings in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 64.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 49,426…
Skandinaviska Enskilda Banken AB publ Makes New $5.72 Million Investment in Ascendis Pharma A/S $ASND
Skandinaviska Enskilda Banken AB publ purchased a new position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased…
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Given Average Recommendation of 'Hold' by Brokerages
Shares of OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) have earned a consensus rating of 'Hold' from the five ratings firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated…
Skandinaviska Enskilda Banken AB publ Has $7.74 Million Stock Position in BridgeBio Pharma, Inc. $BBIO
Skandinaviska Enskilda Banken AB publ lifted its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 152.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned…
Persistent Asset Partners Ltd Purchases Shares of 6,330 Ascendis Pharma A/S $ASND
Persistent Asset Partners Ltd acquired a new position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 6,330 shares…
16,893 Shares in BridgeBio Pharma, Inc. $BBIO Purchased by L & S Advisors Inc
L & S Advisors Inc bought a new stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 16,893 shares of the…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Issues Earnings Results, Beats Expectations By $0.53 EPS
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.81) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.34) by $0.53, Zacks reports.
Receive a Daily briefing on Pharma Industry News
Get Started